These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28661484)

  • 1. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury.
    Martens S; Jeong M; Tonnus W; Feldmann F; Hofmans S; Goossens V; Takahashi N; Bräsen JH; Lee EW; Van der Veken P; Joossens J; Augustyns K; Fulda S; Linkermann A; Song J; Vandenabeele P
    Cell Death Dis; 2017 Jun; 8(6):e2904. PubMed ID: 28661484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.
    Cao M; Chen F; Xie N; Cao MY; Chen P; Lou Q; Zhao Y; He C; Zhang S; Song X; Sun Y; Zhu W; Mou L; Luan S; Gao H
    Cell Death Dis; 2018 Nov; 9(12):1140. PubMed ID: 30442927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein kinase-1γ1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3.
    Lee SY; Kim H; Li CM; Kang J; Najafov A; Jung M; Kang S; Wang S; Yuan J; Jung YK
    Cell Death Dis; 2019 Dec; 10(12):923. PubMed ID: 31801942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin inhibits necroptosis.
    von Mässenhausen A; Tonnus W; Himmerkus N; Parmentier S; Saleh D; Rodriguez D; Ousingsawat J; Ang RL; Weinberg JM; Sanz AB; Ortiz A; Zierleyn A; Becker JU; Baratte B; Desban N; Bach S; Schiessl IM; Nogusa S; Balachandran S; Anders HJ; Ting AT; Bleich M; Degterev A; Kunzelmann K; Bornstein SR; Green DR; Hugo C; Linkermann A
    Cell Death Dis; 2018 Mar; 9(3):359. PubMed ID: 29500402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
    Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
    Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
    Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
    J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression.
    Zhu K; Liang W; Ma Z; Xu D; Cao S; Lu X; Liu N; Shan B; Qian L; Yuan J
    Cell Death Dis; 2018 May; 9(5):500. PubMed ID: 29703889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis.
    Shi FL; Yuan LS; Wong TS; Li Q; Li YP; Xu R; You YP; Yuan T; Zhang HR; Shi ZJ; Zha QB; Hu B; He XH; Ouyang DY
    Pharmacol Res; 2023 Mar; 189():106697. PubMed ID: 36796462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necroptosis and Inflammation.
    Newton K; Manning G
    Annu Rev Biochem; 2016 Jun; 85():743-63. PubMed ID: 26865533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
    Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
    Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis.
    Rodriguez DA; Weinlich R; Brown S; Guy C; Fitzgerald P; Dillon CP; Oberst A; Quarato G; Low J; Cripps JG; Chen T; Green DR
    Cell Death Differ; 2016 Jan; 23(1):76-88. PubMed ID: 26024392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis.
    Remijsen Q; Goossens V; Grootjans S; Van den Haute C; Vanlangenakker N; Dondelinger Y; Roelandt R; Bruggeman I; Goncalves A; Bertrand MJ; Baekelandt V; Takahashi N; Berghe TV; Vandenabeele P
    Cell Death Dis; 2014 Jan; 5(1):e1004. PubMed ID: 24434512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
    Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
    FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necroptosis directly induces the release of full-length biologically active IL-33 in vitro and in an inflammatory disease model.
    Shlomovitz I; Erlich Z; Speir M; Zargarian S; Baram N; Engler M; Edry-Botzer L; Munitz A; Croker BA; Gerlic M
    FEBS J; 2019 Feb; 286(3):507-522. PubMed ID: 30576068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis in development, inflammation and disease.
    Weinlich R; Oberst A; Beere HM; Green DR
    Nat Rev Mol Cell Biol; 2017 Feb; 18(2):127-136. PubMed ID: 27999438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pan-RAF inhibitor LY3009120 inhibits necroptosis by preventing phosphorylation of RIPK1 and alleviates dextran sulfate sodium-induced colitis.
    Zhang C; Luo Y; He Q; Liu S; He A; Yan J
    Clin Sci (Lond); 2019 Apr; 133(8):919-932. PubMed ID: 30944150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
    Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
    Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.